• 1. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 2. An investigation of new infrared nonlinear optical material: BaCdSnSe4, and three new related centrosymmetric compounds: Ba2SnSe4, Mg2GeSe4, and Ba2Ge2S6?
  Kui Wu,Zhihua Yang,Shilie Pan Dalton Trans., 2015,44, 19856-19864
• 3. An artificial photosynthetic system for photoaccumulation of two electrons on a fused dipyridophenazine (dppz)–pyridoquinolinone ligand?
  Philipp Traber,Stephan Kupfer,Stefanie Gr?fe,Isabelle Baussanne,Martine Demeunynck,Jean-Marie Mouesca,Serge Gambarelli,Vincent Artero,Murielle Chavarot-Kerlidou Chem. Sci., 2018,9, 4152-4159
• 4. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 5. Alternative donor substrates for inverting and retaining glycosyltransferases?
  Luke L. Lairson,Warren W. Wakarchuk Chem. Commun., 2007, 365-367

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Triazines 1,3,5-triazines Alkyl-2-thio-S-triazines

Introduction to 2-({7-methyl-4-oxo-4H-pyrido1,2-a1,3,5triazin-2-yl}sulfanyl)-N-(propan-2-yl)acetamide and Its Significance in Modern Chemical Biology

Chemical compounds play a pivotal role in the advancement of pharmaceutical sciences, particularly in the development of novel therapeutic agents. Among these, 2-({7-methyl-4-oxo-4H-pyrido1,2-a1,3,5triazin-2-yl}sulfanyl)-N-(propan-2-yl)acetamide, with the CAS number 896325-13-6, has garnered significant attention due to its unique structural properties and potential biological activities. This compound belongs to a class of heterocyclic sulfonamides that have been extensively studied for their pharmacological effects. The intricate molecular framework of this compound, characterized by a pyrido[1,2-a]triazine core, makes it a promising candidate for further investigation in drug discovery.

The pyrido[1,2-a]triazine scaffold is a well-known pharmacophore in medicinal chemistry, known for its ability to interact with various biological targets. This scaffold is part of a larger family of nitrogen-containing heterocycles that exhibit a wide range of biological activities, including antimicrobial, anti-inflammatory, and anticancer properties. The presence of a sulfanyl group at the 2-position of the triazine ring enhances the compound's potential to interact with biological receptors, thereby modulating cellular processes.

In recent years, there has been a surge in research focused on developing novel sulfonamide derivatives as potential therapeutic agents. Sulfonamides are known for their broad spectrum of biological activities and have been successfully used in the treatment of various diseases. The compound 2-({7-methyl-4-oxo-4H-pyrido1,2-a1,3,5triazin-2-yl}sulfanyl)-N-(propan-2-yl)acetamide is no exception and has been the subject of several studies aimed at elucidating its mechanism of action and potential therapeutic applications.

The< strong>N-(propan-2-yl)acetamide moiety in the compound's structure contributes to its pharmacological profile by enhancing its solubility and bioavailability. This feature is crucial for drug development, as it ensures that the compound can be effectively absorbed and distributed throughout the body. Additionally, the propanyl group may play a role in modulating the compound's interactions with biological targets by influencing its conformational flexibility.

Recent studies have highlighted the importance of understanding the structural features of heterocyclic compounds in relation to their biological activity. Computational modeling and molecular dynamics simulations have been instrumental in predicting how these compounds interact with biological targets at the molecular level. These studies have provided valuable insights into the design of more effective and selective therapeutic agents.

The< strong>7-methyl-4-oxo-4H-pyrido1,2-a1,3,5triazin-2-yl sulfanyl group is particularly interesting from a chemical biology perspective. This moiety has been shown to exhibit significant binding affinity for certain enzymes and receptors involved in critical cellular pathways. By targeting these pathways, the compound may be able to modulate various physiological processes, making it a potential candidate for treating conditions such as inflammation and cancer.

In addition to its potential therapeutic applications, 2-(7-methyl-pyrido[1,2-a]triazinylsulfanyl)-N-(propanaldehyde)acetamide has also been studied for its role in chemical biology research. The compound's unique structure makes it a valuable tool for investigating the function of various biological targets. By studying how this compound interacts with different proteins and enzymes, researchers can gain insights into the mechanisms underlying various diseases and develop more effective treatments.

The synthesis and characterization of this compound have been challenging due to its complex structure. However, advances in synthetic chemistry have made it possible to produce high-quality samples for further study. These efforts have led to a better understanding of the compound's properties and its potential applications in drug development.

The< strong>CAS number 89632513 associated with this compound serves as an identifier for researchers worldwide. This standardized system allows scientists to easily locate and reference specific chemical substances in their studies. The CAS registry number ensures that information about this compound is accurately recorded and accessible to the scientific community.

Ongoing research continues to explore the full potential of< strong>89632513. Studies are being conducted to evaluate its efficacy in preclinical models and to identify any potential side effects or toxicities. These investigations are crucial steps toward determining whether this compound can be safely translated into clinical use for treating human diseases.

The< strong>CAS registry number 89632513, assigned by Chemical Abstracts Service (CAS), is an essential tool for chemists and biologists working in pharmaceutical research. It provides a unique identifier for each chemical substance listed in CAS databases. This system ensures that researchers can accurately reference specific compounds across different publications and databases.

In conclusion,< strong>89632513, also known as 89632513, represents an exciting advancement in chemical biology research. Its unique structural features make it a promising candidate for further investigation as a therapeutic agent. As research continues to uncover new insights into its properties and potential applications,< strong>89632513 is poised to play an important role in future medical treatments.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)